Format

Send to

Choose Destination
Nat Rev Drug Discov. 2018 Mar;17(3):151-152. doi: 10.1038/nrd.2017.246. Epub 2017 Dec 15.

Addressing challenges in the diagnosis and treatment of rare genetic diseases.

Author information

1
Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario K1H 8L1, Canada.
2
International Rare Diseases Research Consortium.
3
Corporate Drug Development, Chiesi Farmaceutici S.p.A., Largo Belloli 11/A, 43122 Parma, Italy.

Abstract

The past 5 years have seen an unprecedented rate of discovery of genes that cause rare diseases and with it a commensurate increase in the number of diagnosable but nevertheless untreatable disorders. Here, we discuss the increasing opportunity for diagnosis and therapy of rare diseases and how to tackle the associated challenges.

PMID:
29242613
DOI:
10.1038/nrd.2017.246

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center